Nutritional composition made using isolated organic matter
View Patent ↗Nutritional compositions, formulations, and intermediates are provided which may be utilized to formulate various sweeteners and other products. The formulations described herein are made from constituents found in soils or fossilized soils.
1. An extract composition comprising sterile fossilized soil organic matter (SFSOM) extracted from fossilized soil wherein the (SFSOM) includes N-acetylglucosamine of Formula 1:
and mannose of Formula 3:
wherein the N-acetylglucosamine (NAG) is present at a concentration of from about 0.05 mg/1.0 gm to about 100 mg/1.0 gm, based on the total weight of the extract composition;
wherein the mannose (MANN) is present at a concentration of from about 0.05 mg/1.0 gm to about 100 mg/1.0 gm, based on the total weight of the extract composition;
wherein said (SFSOM) has a first sterile profile (i) of <100 cfu/gram aerobic plate count measured according to AOAC 990.12; and
wherein components of the (SFSOM) including (NAG) and (MANN) are not isolated from the extract.
2. The extract composition of claim 1 , wherein said (SFSOM) has a second sterile profile (ii) of <10 cfu/gram coliform count measured according to AOAC 991.14.
3. The extract composition of claim 2 , wherein said (SFSOM) has a third sterile profile (iii) of <10 cfu/gram yeast measured according to FDA-BAM, 7th ed.
4. The extract composition of claim 2 , wherein said (SFSOM) has a third sterile profile (iii-a) of <10 cfu/gram yeast measured according to FDA-BAM, 8th ed.
5. The extract composition of claim 3 , wherein said (SFSOM) optionally has a fourth sterile profile (iv) of <10 cfu/gram mold measured according to FDA-BAM, 7th Edition.
6. The extract composition of claim 3 , wherein said (SFSOM) has a fourth sterile profile (iv-a) of <10 cfu/gram mold measured according to FDA-BAM, 8th Edition.
7. The extract composition of claim 2 , wherein said (SFSOM) optionally has a fourth sterile profile (iv-b) of ≦10 cfu/gram mold measured according to FDA-BAM, 7th Edition.
8. The extract composition of claim 2 , wherein said (SFSOM) has a fourth sterile profile (iv-c) of ≦10 cfu/gram mold measured according to FDA-BAM, 8th Edition.
9. The extract composition of claim 1 , further comprising one or more amino acids, or salts thereof, selected from the group consisting of: arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, serine, threonine, tryptophan, valine, alanine, aspartic acid, asparagine, cysteine, glutamic acid, glutamine, glycine, proline, and tyrosine.
10. The extract composition of claim 1 further comprising one or more of an element selected from the group consisting of, and at a corresponding concentration of about:
Element
ppm
Al
23,900
Ga
22
Sm
78
Sb
44
Ge
77
Sc
24
As
6
Hf
4
Se
795
Ba
1.6
Ho
11
Si
310
Be
21.7
In
27
Ag
5
Bi
280
Fe
104,563
Na
12
B
340
La
128
Sr
62
Br
5
Li
9
S
26,800
Ca
2,700
Lu
6
Te
2
C
600
Mg
9,400
Tb
9
Ce
24
Mn
520
Tl
17
Cs
7
Nd
280
Th
98
Cl
81
Ni
104
Tm
55
Cr
385
Os
2
Sn
18
Co
75
P
580
Ti
3
Cu
13
K
6
V
780
Dy
51
Pr
66
Yb
27
Er
40
Re
11
Y
260
F
8
Rb
630
Zn
1,850
Gd
109
Ru
8
and Zr
5.
11. The extract composition of claim 1 further comprising one or more of an element selected from the group consisting of: Al, Sb, As, Ba, Be, Bi, B, Br, Ca, C, Ce, Cs, Cl, Cr, Co, Cu, Dy, Er, F, Gd, Ga, Ge, Hf, Ho, In, Fe, La, Li, Lu, Mg, Mn, Nd, Ni, Os, P, K, Pr, Re, Rb, Ru, Sm, Sc, Se, Si, Ag, Na, Sr, S, Te, Tb, Tl, Th, Tm, Sn, Ti, V, Yb, Y, Zn, and Zr.
12. The extract composition of claim 1 further comprising a member selected from the group consisting of a monosaccharide, an oligosaccharide, a disaccharide, an amino acid, humic acid, fulvic acid, humifulvic acid, a mineral and combinations thereof.
13. The extract composition of claim 12 , wherein the composition has a glycemic index (GI) between about 35 and about 55.
14. The extract composition of claim 1 having a pH from about 1 to about 4.
15. The extract composition of claim 1 having a pH from about 1.7 to about 2.9.
16. A process for making sterile fossilized soil organic matter (SFSOM) extracted from fossilized soil wherein the (SFSOM) includes N-acetylglucosamine of Formula 1:
and mannose of Formula 3:
wherein the N-acetylglucosamine (NAG) is present at a concentration of from about 0.05 mg/1.0 gm to about 100 mg/1.0 gm, based on the total weight of the extract composition;
wherein the mannose (MANN) is present at a concentration of from about 0.05 mg/1.0 gm to about 100 mg/1.0 gm, based on the total weight of the extract composition; and
wherein components of the (SFSOM) including (NAG) and (MANN) are not isolated from the extract;
said process comprising the steps of:
(a) extracting fossilized soil (FS) with an aqueous solvent to form a liquid extract including one or more of monosaccharides, amino acids, antioxidants, oligosaccharides, minerals or a combination thereof; and
(b) sterilizing the liquid extract such that said (SFSOM) has a first sterile profile (i) of <100 cfu/gram (SFSOM) of aerobic plate count measured according to AOAC 990.12.
17. The process of claim 16 , wherein the (FS) is native to North America.
18. The process of claim 17 wherein the extracting step (a) comprises drip extraction with water; wherein the liquid extract has a pH from about 1 to about 4; wherein the minerals are selected from the group consisting of Al, Sb, As, Ba, Be, Bi, B, Br, Ca, C, Ce, Cs, Cl, Cr, Co, Cu, Dy, Er, F, Gd, Ga, Ge, Hf, Ho, In, Fe, La, Li, Lu, Mg, Mn, Nd, Ni, Os, P, K, Pr, Re, Rb, Ru, Sm, Sc, Se, Si, Ag, Na, Sr, S, Te, Tb, Tl, Th, Tm, Sn, Ti, V, Yb, Y, Zn, Zr and combinations thereof; and wherein the amino acids, or salts thereof, are selected from the group consisting of: arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, serine, threonine, tryptophan, valine, alanine, aspartic acid, asparagine, cysteine, glutamic acid, glutamine, glycine, proline, tyrosine, and combinations thereof.
19. The process of claim 16 , wherein the sterilizing step (b) provides the (SFSOM) with a second sterile profile (ii) of <10 cfu/gram coliform count measured according to AOAC 991.14, and optionally a third sterile profile (iii) of <10 cfu/gram of yeast measured according to FDABAM, 7th Edition.
20. The process of claim 19 , further comprising the steps of:
(c) adding an amount of soluble phosphate to a sterilized liquid extract having the first, second, and optionally third sterile profile sufficient to precipitate out iron from the sterilized liquid extract; and
(d) optionally separating out the precipitate from the sterilized liquid extract of step (c) to give a substantially clear sterilized liquid extract essentially free of dissolved Fe therein.
21. The process of claim 20 , further comprising the steps of:
(e) adding a disaccharide to the sterilized liquid extract essentially free of dissolved Fe therein to yield a disaccharide solution;
(f) adding a source of xylose, glucose, or mixture thereof into the disaccharide solution;
(g) optionally mixing the disaccharide solution until the color of the disaccharide solution turns or is green; and
(h) optionally drying the disaccharide solution to give a green precipitate.
22. The process of claim 21 , wherein the disaccharide comprises fructose and glucose optionally at a 50:50 (w/w) ratio.
23. The process of claim 21 , wherein the source of xylose, glucose, or mixture thereof comprises raw arabica.
24. The process of claim 16 , wherein said (SFSOM) exhibits an Oxygen Radical Absorbance Capacity (ORAC) rating of about 2,320 in micromole Trolox equivalent per liter units.
25. The process of claim 19 , wherein the sterilizing step (b) provides the (SFSOM) with a third sterile profile (iii) of <10 cfu/gram of yeast measured according to FDA BAM, 7th ed., and optionally a fourth sterile profile (iv) of <10 cfu/gram of mold measured according to FDA-BAM, 7th Edition.
26. The process of claim 21 , further comprising the steps of:
(i) adding an amount of a soluble phosphate to a sterilized liquid extract having the first, second, and optionally third sterile profile sufficient to precipitate out iron from the sterilized liquid extract; and
(j) optionally separating out the precipitate from the sterilized liquid extract (FNC) of step (c) to give a substantially clear sterilized liquid extract (FNC) essentially free of dissolved Fe therein; and
(k) optionally heating said (FNC) sufficient to have the first, second, and/or third sterile profile.
27. The process of claim 26 , wherein said soluble phosphate is Potassium Phosphate Monobasic (PPM).
28. The process of claim 16 , wherein the said sterilization step (b) further comprises heating the liquid extract to about 180° F., but not to exceed a temperature or a time that substantially destroys the constituent monosaccharides, minerals, amino acids, antioxidants or oligosaccharides in the extract.
29. The extract composition of claim 1 , wherein the (SFSOM) contains no Fe or essentially no (Fe).
30. The process of claim 21 , further comprising the step of:
( 1 ) optionally adding fibersol, mangosteen, and/or acai berry to the disaccharide solution.
31. The process of claim 16 , wherein one or more of raw arabica, fibersol, mangosteen, or acai berry is added to the liquid extract before or after said sterilization step(b).